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Abstract
Background: There is a dearth of standardized studies examining exposure to environmental tobacco
smoke (ETS) and its relationship to respiratory health among adults in developing countries.
Methods: In 2004, the Syrian Center for Tobacco Studies (SCTS) conducted a population-based survey
using stratified cluster sampling to look at issues related to environmental health of adults aged 18–65
years in Aleppo (2,500,000 inhabitants). Exposure to ETS was assessed from multiple self-reported indices
combined into a composite score (maximum 22), while outcomes included both self-report (symptoms/
diagnosis of asthma, bronchitis, and hay fever), and objective indices (spirometric assessment of FEV1 and
FVC). Logistic and linear regression analyses were conducted to study the relation between ETS score and
studied outcomes, whereby categorical (tertiles) and continuous scores were used respectively, to
evaluate the association between ETS exposure and respiratory health, and explore the dose-response
relationship of the association.
Results: Of 2038 participants, 1118 were current non-smokers with breath CO levels ≤ 10 ppm (27.1%
men, mean age 34.7 years) and were included in the current analysis. The vast majority of study
participants were exposed to ETS, whereby only 3.6% had ETS score levels ≤ 2. In general, there was a
significant dose-response pattern in the relationship of ETS score with symptoms of asthma, hay fever, and
bronchitis, but not with diagnoses of these outcomes. The magnitude of the effect was in the range of
twofold increases in the frequency of symptoms reported in the high exposure group compared to the
low exposure group. Severity of specific respiratory problems, as indicated by frequency of symptoms and
health care utilization for respiratory problems, was not associated with ETS exposure. Exposure to ETS
was associated with impaired lung function, indicative of airflow limitation, among women only.
Conclusions: This study provides evidence for the alarming extent of exposure to ETS among adult non-
smokers in Syria, and its dose-response relationship with respiratory symptoms of infectious and non-
infectious nature. It calls for concerted efforts to increase awareness of this public health problem and to
enforce regulations aimed at protecting non-smokers.
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Introduction
The deleterious effects of exposure to ETS on the respira-
tory system of adults and children is well documented [1-
4]. Exposure to ETS not only influences respiratory health
among those affected but also leads to increased health
care utilization and costs because of respiratory problems
[5,6]. For example, a recent study investigating more than
10,000 children in Germany showed that the risk of emer-
gency department visits and hospitalizations from asthma
was more than double for children exposed to 10 or more
cigarettes/day compared to less exposed children [6]. ETS
exposure was found to be associated with respiratory
symptoms, abnormal lung functions, and increased bron-
chial responsiveness in children and adults [1-4,7,8]. Of
special significance for developing countries, lower respi-
ratory infection, the single most important cause of death
for children below the age of 5 years, has been found to be
associated with exposure to ETS [1,9-12]. However, with
most studies of ETS exposure and respiratory health being
done in developed countries, local evidence to promote
clean air policies and to enforce existing policies are lack-
ing in most of the developing world.
The situation with exposure to ETS in developing coun-
tries is likely to be aggravated by the widespread of smok-
ing, lack of restrictions regarding indoor smoking,
overcrowded housing conditions, and failure of health
services [13-15]. Cigarette smoking in Aleppo is affecting
some 70% of men and 20% of women aged 30–45 years,
with an average of 1.2 cigarette smoker per household
[16]. Moreover, Syria as well as other countries in the East-
ern Mediterranean region (EMR) are experiencing an
alarming increase in the popularity of waterpipe smoking
[17,18]. Although this form of smoking is generally con-
sidered an outdoor social practice, research done at the
Syrian Center for Tobacco Studies (SCTS) shows that
more serious smokers demonstrate a predominantly indi-
vidual use pattern (home, and alone) [19]. As such, water-
pipe smoking may be an important source of ETS due to
its emissions and length of smoking bouts [18,20]. Assess-
ment of exposure to ETS, therefore, needs to encompass
all information relevant to the studied setting and the
smoking patterns of the target population.
Despite these troubling facts, there is a dearth of research
examining the relationship between ETS exposure and res-
piratory health in developing countries, with the few
available studies limited by poor outcome definition, lack
of systematic exposure assessment, and inadequate con-
trol of confounding [21,22]. A recent review of this sub-
ject identifies a major limitation of available data being
restricted to industrialized nations [3]. Generally, the use
of different methodologies and markers of exposure and
outcome precludes arriving at a clear picture of the rela-
tionship between ETS exposure and respiratory health. For
example, not all studies have found a relationship
between exposure to ETS and lung function impairment
[23,24], some did not find a dose-response relationship
[25], while others demonstrated gender-specific effects
[24,26]. The reliance on single or historic indicators of
exposure (spouse's smoking, maternal smoking during
pregnancy) can lead to an imprecise estimation of expo-
sure or recall problems [27,28]. Previous quantitative and
qualitative research done in Aleppo has identified ETS as
a potentially major health hazard in the indoor environ-
ment [16,29]. The current study, which is the first to assess
respiratory health of adults and its relation to ETS expo-
sure in Syria, is based on a population-based household
survey (Aleppo Household Survey, AHS) done in Aleppo
in 2004 utilizing multiple self-reported indicators of
exposure and outcome as well as expired breath CO and
spirometry.
Methods
Population and sampling
The target population consisted of adults 18–65 years of
age residing in the greater city of Aleppo (around
2,500,000 inhabitants). Detailed description of the sam-
pling design and procedures of the AHS is reported else-
where and illustrated in Figure 1[16]. Briefly, stratified
cluster sampling was used where residential neighbor-
hoods of the city were stratified into two strata: formal
and informal; according to the official description of the
municipal registry (Figure 1). From each stratum, residen-
tial neighborhoods were randomly selected with proba-
bility proportional to size (PPS). Within each
neighborhood, households were selected with equal
probably and an adult was randomly selected from each.
The survey was conducted between May-August 2004, and
the protocol and the informed consent documents were
approved by the Institutional Review Boards at the Uni-
versity of Memphis and SCTS.
Design and procedures
This interviewer-administered survey involved six, 2-per-
son, mixed gender teams of surveyors equipped with
notebook computers programmed to record question-
naire responses and measurements using a custom data
entry program (Delphi programming language and SQL
server DBMS). The questionnaire included 8 main sec-
tions; socio-demographics, general health and disability,
chronic disease, respiratory health, household members'
health, environmental health, smoking, and ETS expo-
sure. For the assessment of respiratory health and risks,
the questionnaire was developed based on relevant instru-
ments (especially the European Community Respiratory
Health Survey-ECRHS, the International Study of Asthma
and Allergy in Children-ISAAC, and ETS exposure assess-
ment instrument developed by Eisner and colleagues), asRespiratory Research 2005, 6:13 http://respiratory-research.com/content/6/1/13
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well surveys done in Syria [29-35]. Next, the survey instru-
ment and strategy were modified in terms of format, con-
tent, language, response categories, and recall period
based on formative work conducted with key informants
involved in the provision of health care as well as with res-
idents, in addition to piloting in 20 randomly selected
households [16,29]. After being randomly selected, all
study participants underwent the detailed study interview
and objective measurements; height using a sliding wall
meter (Seca, Germany), body weight using digital scales
(Camry, China), expired breath carbon monoxide (CO)
using breath CO monitors (Vitalograph, US), and lung
function tests using portable spirometers (Micro-plus,
UK) according to a standard protocol (16).
Exposure
Data from self-reported non-smokers (both cigarettes and
waterpipe), validated by breath CO levels ≤ 10 ppm
(Table 1) [36,37], were analyzed for this report. ETS expo-
sure assessment utilized responses to multiple inquiries
about short- vs. long-term, indoor vs. outdoor, and ciga-
rette vs. waterpipe exposures, as well as sensory irritation
due to ETS exposure (a marker of intensity of exposure)
(Table 2) [29-35]. Spouse's and parental smoking assess-
ment included inquiries about length, intensity, and type
of smoking (cigarette, waterpipe). Occupational exposure
to respirable pollutants other than ETS was assessed by
asking those involved in paid work whether they are
exposed to dust, foams, smoke or other respirable parti-
cles at their work categorized as no exposure, mild expo-
sure (a day or less weekly), moderate exposure (more than
a day per week but not daily), and severe exposure (almost
daily). Parental allergy was assessed by asking whether the
respondent's parents ever suffered from respiratory or
The overall sampling scheme of the Aleppo Household  Survey Figure 1
The overall sampling scheme of the Aleppo Household Sur-
vey. In the 1st step the target population was divided into two 
strata, formal and informal zones (where residential areas are 
build illegally or on a land not designated for housing). In the 
next step residential neighborhoods were selected with PPS, 
and within selected neighborhoods households and one adult 
within each were selected with equal probability.
Table 1: Basic indicators of Aleppo Household Survey (AHS) 
participants (n = 2038), and non-smokers satisfying criteria for 
inclusion in the analysis (n = 1118)
All participants 
n (%)
Non-smokers with breath 
CO ≤10 ppm n (%)
Age
18–29 years 736 (36.1) 450 (40.3)
30–45 years 874 (42.9) 418 (37.4)
46–65 years 428 (21.0) 250 (22.4)
Gender
Men 921 (45.2) 303 (27.1)
Women 1117 (54.8) 815 (72.9)
Religion
Muslim 1938 (95.3) 1073 (96.1)
Christian 82 (4.0) 37 (3.3)
Other 13 (0.6) 6 (0.5)
Race
Arabs 1625 (79.9) 912 (81.6)
Non-Arabs 409 (20.1) 205 (18.4)
Education
Illiterate 425 (20.9) 257 (23.0)
≤ 9 years 1131 (55.5) 578 (51.7)
> 9 years 482 (23.7) 283 (25.3)
mean ± SD mean ± SD
Total number of 
people in the 
household
6.5 ± 3.3 6.7 ± 3.2
Adults 3.3 ± 1.8 3.5 ± 1.9
Children 3.2 ± 2.5 3.2 ± 2.5
Household density 
(household/rooms)
2.2 ± 1.3 2.2 ± 1.3
Total SES score 4.3 ± 2.0 4.0 ± 2.0Respiratory Research 2005, 6:13 http://respiratory-research.com/content/6/1/13
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nose allergy with responses categorized into none, father,
mother, or both.
Outcomes
Past year recurrent cough and recurrent shortness of
breath were defined as having 3 or more recognizable epi-
sodes of these symptoms. Those reporting recurrent cough
or shortness of breath were asked to select, from a pro-
vided list, one or more options that best described their
symptoms (Table 3). The main asthma symptom (past
year wheezing/whistling in the chest) and asthma diagno-
sis were inquired about from all participants, while other
asthma symptoms (recurrent cough accompanied by
wheezing, recurrent nocturnal cough unrelated to colds,
and recurrent episodic shortness of breath accompanied
by wheezing) were inquired about among those reporting
recurrent cough or shortness of breath. Items related to
physician-diagnosed conditions included ever having a
diagnosis of (asthma, chronic bronchitis, or emphysema),
or the occurrence of a diagnosed condition (sinusitis,
acute bronchitis, pneumonia) during the past year. Hay
fever was defined conservatively based on positive
responses to two questions about past year nasal allergic
symptoms (episodes of sneezing, runny or blocked nose
when not experiencing a cold), and the co-occurrence of
itchy and watery eyes [38]. Severity of respiratory com-
plaints was based on the number of wheezing/whistling
episodes for asthma (≤ 12 and > 12), reporting more than
one episode of sinusitis or acute lower respiratory tract
infection, and medical care (medication use, hospital or
clinic visits) for respiratory problems (Table 4). Medica-
tion or health facility use because of respiratory problems
was broken down further by condition (asthma, pneumo-
nia, bronchitis, etc.), but because none of these outcomes
were associated with exposure to ETS in our study we used
only the parent general question.
Forced Expiratory Volume in the 1st second (FEV1) and
Forced Vital Capacity (FVC) were measured for all partici-
pants according to standard guidelines [39]. We used
hand-held spirometer (Micro-plus, Micro Medical,
Rochester, UK), which have been shown to have good pre-
cision and reproducibility [40]. We used newly calibrated
spirometers and tested them weekly by team members
with known lung functions (allowing for no more than
5% variation between different spirometers). Multiple
maneuvers were performed until three satisfactory ones
were recorded. The best effort that did not exceed the next
best by more than 5% was included in the analysis [41]
(Table 5).
Analysis
Descriptive statistics were calculated for the overall study
population and for measures of ETS exposure among non-
smokers (Tables 1,2). Composite scores for socioeco-
nomic status (SES score) and self-reported ETS exposure
indices were constructed for the analysis (as illustrated in
the additional file, Appendix 1). Spearman correlation
coefficients were calculated to assess the relation between
FEV1, FVC, FEV1/FVC and ETS score. Logistic regression
was used to estimate the odds ratio (OR) and the 95%
Table 2: Various indicators of exposure to ETS among adults 
non-smokers (n = 1118) in Aleppo, Syria.
Non-smokers 
with CO≤10 
ppm n (%)
Spouse's smoking (cigarettes and waterpipe) 351 (43.7)*
Parental smoking
None 374 (33.5)
Father 591 (52.9)
Mother 36 (3.2)
Both 117 (10.5)
Number of household smokers
Cigarettes ≥ 1 smoker 543 (48.6)
Waterpipe ≥ 1 smoker 47 (4.2)
Both ≥ 1 smoker 108 (9.7)
Past year regular exposure to other's smoke 769 (68.8)
Past week sensory irritation from ETS exposure
Sometimes 188 (16.8)
Many times 103 (9.2)
Past week hours spent daily with smokers
At home 
≤ 1 hour/day 651 (58.2)
>1 hour/day 467 (41.8)
At other places 
≤ 1 hour/day 795 (71.1)
>1 hour/day 323 (28.9)
Exposure to smoking at workplace
Yes/well ventilated 205 (58.9)*
Yes/poor ventilated 32 (9.2)*
Average cigarettes smoked daily in the house
1–10 cig/day 438 (39.2)
> 10 cig/day 281 (25.1)
Average waterpipes smoked daily in the house
1–2 waterpipe/day 33 (3.0)
> 2 waterpipe/day 8 (0.7)
House policy regarding smoking
Smoking is not allowed at all 40 (3.6)
Smoking is allowed for only few guests 137 (12.3)
Smoking is allowed only in special places 106 (9.5)
Smoking is not restricted at all 812 (72.6)
Differs between cigarettes and waterpipes 23 (2.1)
* Calculated from the number of non-smokers who are currently 
married (n = 803), or employed (n = 348)Respiratory Research 2005, 6:13 http://respiratory-research.com/content/6/1/13
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confidence interval for the relation between ETS score and
respiratory symptoms adjusting for age, sex, SES score,
parental allergy, occupational exposure to other respira-
tory pollutants, and pack years (for ex-daily smokers). Lin-
ear regression analysis was used to assess the relationship
between ETS score and lung function (FEV1, FVC, and
FEV1/FVC) adjusting for age, BMI, SES score, and occupa-
tional exposure to other respiratory irritants, as well as
interaction terms of age with height and weight. This anal-
ysis was performed separately for men and women, since
lung development and response to ETS has been shown to
differ by gender [26,28]. In both multivariate models
(logistic, linear), ETS score was first entered as a categori-
cal variable (low; bottom tertile, middle; middle tertile,
high; top tertile) for the calculation of OR for different
gradients of exposure, then as continuous variable for the
calculation of p for dose-response relationship. Because of
the concern that ex-smokers may avoid ETS exposure and
have respiratory problems (giving us a group with poten-
tially most respiratory problems but least exposure), we
Table 3: Relation between different levels of exposure to ETS and respiratory symptoms/diagnosis among adult non-smokers in 
Aleppo-Syria (n = 1118)
ETS score*
Self-reported respiratory symptoms/diagnoses middle high P Dose-response
General respiratory symptoms
Past year recurrent cough (≥ 3 recognizable episodes) 1.3 (0.8–1.9) 1.9 (1.2–2.9) 0.004
Past year recurrent shortness of breath (≥ 3 recognizable episodes) 1.6 (1.1–2.3) 1.7 (1.1–2.6) 0.001
Past year recurrent exertional shortness of breath that disappears after rest 1.8 (1.2–2.7) 2.0 (1.3–3.2) <0.001
Past year recurrent shortness of breath almost all the time 3.0 (1.3–6.8) 2.6 (1.1–6.3) 0.02
Symptoms/diagnosis suggestive of asthma
Past year wheezing/whistling in the chest 1.4 (0.8–2.2) 1.7 (1.0–2.8) 0.05
Past year recurrent episodic dry cough accompanied by wheezing/whistling 1.9 (1.0–3.7) 1.9 (0.9–3.9) 0.05
Past year recurrent nocturnal cough, not related to colds, that wakes the subject up 1.2 (0.7–1.9) 1.9 (1.1–3.2) 0.02
Past year recurrent episodic shortness of breath accompanied by wheezing 2.2 (1.1–4.4) 1.6 (0.7–3.7) 0.06
Ever diagnosed asthma 1.8 (1.2–2.8) 1.4 (0.9–2.4) 0.1
Hay fever (nasal allergy symptoms with eye itching and watering) 0.9 (0.6–1.3) 1.5 (0.9–2.3) 0.01
Symptoms/diagnosis suggestive of chronic bronchitis
Productive cough that lasts most of the winter 1.2 (0.7–2.2) 1.6 (0.8–2.9) 0.2
Recurrent shortness of breath accompanied by cough and phlegm 2.2 (1.1–4.7) 2.5 (1.1–5.6) 0.02
Ever diagnosed chronic bronchitis/emphysema 1.1 (0.5–2.2) 1.2 (0.5–2.7) 0.6
Symptoms/diagnosis suggestive of respiratory infection
Past year recurrent cough accompanying upper respiratory infections (cold, flue) 1.0 (0.7–1.6) 1.5 (0.9–2.4) 0.1
Past year recurrent cough with bloody phlegm 1.1 (0.5–2.6) 1.4 (0.6–3.4) 0.7
Past year sinusitis 1.0 (0.6–1.7) 1.7 (1.0–2.9) 0.09
Past year diagnosed acute lower respiratory infection (bronchitis, pneumonia) 1.3 (0.7–2.3) 1.9 (1.1–3.6) 0.03
* Odds ratio and 95% confidence interval for the relation between ETS score tertiles (lower being referent) and respiratory symptoms/diagnosis 
according to multivariate logistic regression adjusted for age, gender, SES score, hay fever, parental allergy, pack-years (for ex-daily smokers), 
occupational exposure to respirable pollutants other than ETS
Table 4: Relation between different levels of exposure to ETS and severity of respiratory problems of adult non-smokers in Aleppo-
Syria
ETS score*
Severity of respiratory problems middle high P Dose-response
Number of wheezing attacks in the past year (≤12 vs. >12) 0.6 (0.2–2.2) 1.2 (0.3–4.5) 0.6
Number of episodes of sinusitis (once vs. more than once) 0.5 (0.2–1.4) 1.2 (0.4–4.1) 0.3
Number of episodes of acute lower respiratory tract infection (once vs. more than once) 1.4 (0.4–4.6) 0.7 (0.2–2.3) 0.3
Past year doctor's or hospital visit because of respiratory problems 1.4 (0.9–2.1) 1.2 (0.7–2.0) 0.4
Past month medication use for respiratory problems 1.0 (0.5–1.7) 1.0 (0.5–1.9) 0.7
* Odds ratio and 95% confidence interval for the relation between ETS score tertiles (lower being referent) and respiratory symptoms/diagnosis 
according to multivariate logistic regression adjusted for age, gender, SES score, hay fever, parental allergy, pack-years (for ex-daily smokers), 
occupational exposure to respirable pollutants other than ETSRespiratory Research 2005, 6:13 http://respiratory-research.com/content/6/1/13
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repeated the analysis including only never smokers, but
this did not affect the results considerably (analysis not
shown). All analyses were done by SPSS 11.
Results
From a total of 2038 valid survey responses (45.2% men,
mean age 35.3 ± 12.1, response rate 86%), 1118 (27.1%
men) satisfied the inclusion criteria for the exposure-
symptoms analysis (Table 1), and 623 (30% men) for the
exposure-lung functions analysis (Table 5). According to
ETS score (mean ± SD 8.8 ± 3.6, median 9), the vast
majority of non-smokers in our population were exposed
to ETS, whereby only 3.6% had levels ≤ 2 and 21.1% had
levels ≤ 5 (Table 2).
Logistic regression analysis of the relation between ETS
score and self-reported symptoms/diagnosis generally
shows a dose-response association with symptoms and
diagnosed acute lower respiratory tract infection (acute
bronchitis, pneumonia). General respiratory symptoms
associated with exposure to ETS were past year recurrent
cough (ORs for comparison between middle, high, with
the low exposure group were 1.3 and 1.9, respectively,
with p for dose response 0.004), past year recurrent short-
ness of breath (ORs 1.6 and 1.7, p = 0.001), past year
recurrent exertional shortness of breath that disappears
after rest (ORs 1.8 and 2, p < 0.001), past year recurrent
shortness of breath almost all of the time (ORs 3 and 2.6,
p = 0.02). Additionally, several symptoms suggestive of
asthma/allergy were related to ETS exposure, including
past year recurrent wheezing/whistling in the chest (ORs
1.4 and 1.7, p = 0.05), past year recurrent episodic dry
cough accompanied by wheezing (ORs 1.9 and 1.9, p =
0.05), past year recurrent episodic shortness of breath
accompanied by wheezing (ORs 2.2 and 1.6, p = 0.06),
past year recurrent nocturnal cough not related to cold
that wakes the subject up (ORs 1.2 and 1.9, p = 0.02), and
past year hay fever symptoms (ORs 0.9 and 1.5, p = 0.01).
Among symptoms suggestive of chronic bronchitis, ETS
exposure was associated with recurrent shortness of
breath accompanied by cough and phlegm (ORs 2.2 and
2.5, p = 0.02). And finally, past year episodes of acute
lower respiratory infection (bronchitis, pneumonia) were
associated with exposure to ETS (OR 1.3 and 1.9, p = 0.03)
(Table 3).
In contrast, exposure to ETS was not related to severity of
respiratory complaints judged by the number of episodes
(wheezing, sinusitis, acute bronchitis, pneumonia), med-
ical care utilization for respiratory problems in general
(Table 4), as well as medical care utilization for a specific
problem (e.g. asthma, pneumonia, analysis not shown).
In the univariate analysis, there was a weak inverse corre-
lation between ETS score and FEV1 (coefficient -0.1, p <
0.001), FVC (-0.1, p = 0.002), and %FEV1/FVC (-0.6, p =
0.1). Linear regression analysis between ETS exposure
score and lung functions showed significant inverse asso-
ciations with indices of airflow limitation (FEV1 and FEV1/
FVC) only in women. Women in the middle category of
ETS exposure had on average 88 ml deficit in FEV1 and 2%
in FEV1/FVC in comparison to those in the low exposure
category. This association did not show a dose-response
relationship (Table 5).
Discussion
This study shows that exposure to ETS is universal among
non-smoking adults in Aleppo-Syria. This exposure is
associated with respiratory complaints of both infectious
and non-infectious etiology in a dose-response fashion,
suggesting a causal relationship. Unlike data from devel-
oped countries, however, exposure to ETS was not related
Table 5: Relation between exposure to ETS and lung functions among men and women non-smokers (n = 623) in Aleppo-Syria
ETS score
middle high P Dose-response
Men
FEV1 (ml) -46.8 (-215.4 to 121.7) 34.3 (-140.5 to 209.1) 0.3
FVC (ml) 63.9 (-167.5 to 295.3) 147.9 (-89.1 to 385.0) 0.5
FEV1/FVC (%) -1.2 (-3.7 to 1.6) -1.0 (-3.5 to 1.6) 0.5
Women
FEV1 (ml) -87.8 (-164.8 to -10.7) -58.7 (-136.5 to 19.1) 0.3
FVC (ml) 3.1 (-103.8 to 110.1) -72.2 (-182.4 to 38.1) 0.2
FEV1/FVC (%) -2.0 (-3.8 to -0.3) -1.0 (-2.9 to 0.8) 0.1
* Unstandardized linear regression coefficient and 95% confidence interval for the relation between ETS score tertiles (lower being referent) and 
lung function tests adjusted for age, BMI, SES score, hay fever, pack years (for ex-cigarette smokers), occupational exposure, parental allergy, and 
interaction terms of age with height and age with weightRespiratory Research 2005, 6:13 http://respiratory-research.com/content/6/1/13
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to increased severity of asthma or other respiratory condi-
tions judged by symptoms frequency and medical care
utilization because of respiratory problems. ETS exposure
was associated with decrements in lung functions sugges-
tive of airflow limitation (FEV1 and FEV1/FVC) among
women only.
Error and bias in ascertainment are always a concern in
cross-sectional studies, due to imprecise or differential
recall. We tried to minimize such problems by not high-
lighting tobacco or ETS exposure when introducing the
study to participants [42], by using symptoms/diagnosis
descriptors that are native to the target population, and by
assessing multiple indices of both exposures and out-
comes. We have some indicators that such bias was lim-
ited, including lack of associations between a diagnosis of
asthma or chronic bronchitis and ETS score. Remarkably,
recurrent cough with bloody phlegm, one of the poten-
tially most startling respiratory symptoms, was not associ-
ated with ETS exposure in this study, giving further
support of minimal recall bias. Our reliance on self-
reported exposure is also a potential limitation, but stud-
ies have repeatedly shown that self-report is a valid meas-
ure of ETS exposure that correlates with other objective
markers such as cotinine [43-46]. Understandably, the
composite ETS score is a crude quantitative measure of
ETS exposure. We opted for its use to incorporate various
sources of information about exposure to ETS in order to
differentiate between meaningful gradients of exposure
for the purpose of the analysis. On the other hand, the
diversity of information relevant to ETS exposure consid-
ered in this study, in addition to the verification of non-
smoking status by breath CO measurement, and the use of
multiple subjective and objective outcomes, helped delin-
eate the exposed group and conduct a robust analysis.
The widespread exposure to ETS among adults in Aleppo,
suggests that it is rather hard to avoid such exposure in
this environment. The vast majority of non-smokers in
Aleppo are exposed to ETS both at home and outside. This
exposure is sufficiently intense to cause sensory (eye and
nose) irritation for a quarter of nonsmokers. In compari-
son, less than a quarter of non-smokers in a national sam-
ple of 43,732 adults in the US report exposure to ETS [47].
Interestingly, such spread of exposure is occurring in the
face of enacted laws banning smoking in public buildings,
worksites, and transportation in Syria since the nineties
[48]. Our results indicate that these laws are not enforced,
as about two thirds of working non-smokers report expo-
sure to others' smoke at work. Accordingly, these results
should provide solid ground for public health advocates
and authorities to push for the application of policies and
measures to protect non-smokers from this hazardous
exposure. Although not in the realm of laws and regula-
tions, the widespread liberal attitude towards smoking in
the house suggests a general lack of awareness, or dis-
missal, of the health damaging effects of ETS exposure to
household members. Remarkably, about three quarters of
studied households do not restrict indoor smoking what-
soever, and only a small minority (3.6%) has total restric-
tion. This shows that in societies where smoking is rather
a norm, it becomes hard to employ smoking restrictions
even in one's own house. Increasing public awareness of
this health hazard is thus an area where public health
advocacy can make a difference.
In general, this study shows stronger and dose-dependent
relationships of ETS exposure with general respiratory
symptoms (i.e. recurrent cough or shortness of breath)
than with symptoms characteristic of specific respiratory
problems (asthma, bronchitis). Arguably, general symp-
toms are more easily identifiable as well as shared among
many respiratory problems. The magnitude of difference
in self-reported asthma symptoms according to exposure
level is generally in the range of a twofold increase. This
effect magnitude is similar to that reported in adults from
16 European countries (European Community
Respiratory Health Survey, ECRHS), but lower than that
reported from the Swiss Study on Air Pollution and Lung
Diseases in Adults (SAPALDIA) [49,50]. Similar to studies
from developed countries, we found a dose-response rela-
tionship between exposure to ETS and respiratory symp-
toms, implying a causal relationship [28,49-52]. On the
other hand, unlike data from European nations (ECRHS),
we found a 50% increase in hay fever symptoms for the
high exposure group compared to those with low expo-
sure. We defined hay fever according to symptom report,
however, while the ECRHS inquired about suffering from
allergic rhinitis or hay fever [49]. Also, among symptoms
indicative of chronic bronchitis, only recurrent shortness
of breath with cough and phlegm was associated with ETS
exposure in our study, while in the ECRHS ETS exposure
during childhood was associated with increased reporting
of recurrent cough and phlegm in adulthood [28]. Since
cough and phlegm are common symptoms of infectious
respiratory problems, likely to be widespread in our pop-
ulation due to overcrowding and poor housing condi-
tions, such symptoms can be non-specific indicators of
chronic bronchitis in our setting, while shortness of
breath can be more specific marker of this condition.
Level of exposure to ETS in our population was not asso-
ciated with severity of asthma, sinusitis, or lower respira-
tory tract infection. In contrast, in a study of 349 adults
with asthma in the US, Eisner and colleagues found that
exposure to ETS at baseline was associated with more
symptom severity and emergency/hospital admissions
because of asthma at 18 month followup [53]. Medical
care utilization for respiratory problems is likely to be an
inadequate indicator of severity in a low-income countryRespiratory Research 2005, 6:13 http://respiratory-research.com/content/6/1/13
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such as Syria, where the lack of medical insurance and
limited public health services render seeking private
health care the last resort for most adults in this country.
On the other hand, as it will be discussed later, the lack of
a comparison group of non-exposed individuals may have
contributed to the absence of association between ETS
exposure and symptoms severity in this study.
Studies of the relation between exposure to ETS and lung
function have generally shown a detrimental effect of such
exposure. This effect, however, was not consistent and of
low magnitude generally (50–100 ml) [3]. For example,
in a population-based sample of adults from the NHANES
III survey in the US, exposure to ETS was associated with
decreased lung functions (FEV1, FVC, FEV1/FVC) in
women but not men [26]. Data from the ECRHS involv-
ing 18,922 adults from 17 European countries show that
exposure to parental smoking in childhood was associ-
ated with impaired lung function [28]. The effect on lung
function differed, however, according to participant's gen-
der, parental smoking (mother, father, both), and period
of exposure (during pregnancy, childhood) [28]. Our
study shows that exposure to ETS is associated with
decreased lung function indicative of airflow limitation
(FEV1, and FEV1/FVC) in female but not male non-smok-
ers. The reduction for the middle compared to low expo-
sure category was in the magnitude of 88 ml for FEV1 and
2% for FEV1/FVC. Although other studies have reported
similar gender-specific vulnerability of women [26], it is
important to emphasize the small number of male non-
smokers in our sample (less than one third). We also
could not elicit a dose-response in the relation between
ETS exposure and airflow limitation among women,
although ETS score was weakly correlated to FVE1 in the
univariate analysis. It is possible that we are dealing in our
setting with levels of exposure that exceed those occurring
in western societies. Indeed, because of the low magni-
tude of the effect of ETS exposure on lung function, stud-
ies have relied on comparisons of exposed vs. non-
exposed individuals to assess this relationship [49,53-55].
In our sample, however, we had very few subjects with no
or little exposure, which could have reduced the sensitiv-
ity of our analysis. Another possibility is that the relatively
crude measure of ETS (ETS score) we used may better dif-
ferentiate between gradients of exposure at its lower stra-
tum than higher.
Conclusions
This study shows that exposure to ETS is rampant among
adult non-smokers in Syria, where it is hard to escape it
due to a high prevalence of smoking, household over-
crowding, and lack of smoking restrictions. This exposure
is leading to increased respiratory symptoms/disease of
both infectious and non infectious etiologies, and is likely
to have deleterious effects on respiratory function among
women. In addition, the dose-response association found
between exposure to ETS and respiratory symptoms point
towards causal relationship. These results send a clear
message to health advocates and policy makers about the
spread and harmful effects of exposure to ETS in Syria and
on the importance of collective efforts to educate both the
public and authorities about this major health hazard and
ways to effectively protect non-smokers from it. In addi-
tion to giving further support to the health hazards of ETS
exposure, this study can provide guidance for future
research on this issue in other developing countries.
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